Project documents | Larotrectinib for treating NTRK fusion-positive advanced solid tumours (MA review of TA630) [ID6292] | Guidance | NICE

Documents

Documents created during the development process.

Draft guidance

Draft guidance
Draft guidance (downloadable version) (PDF 371 KB)

Published:

01 April 2026
Draft guidance (online commenting)
Committee papers (PDF 7.25 MB)

Published:

01 April 2026
Public committee slides (PDF 771 KB)

Published:

01 April 2026
Equality impact assessment (downloadable version) (PDF 130 KB)

Published:

01 April 2026

Declaration of interests

Register of interests (PDF 141 KB)

Published:

15 April 2026

Invitation to participate

Final scope (PDF 175 KB)

Published:

04 August 2025
Final stakeholder list (PDF 166 KB)

Published:

04 August 2025
NICE's response to comments on the draft scope and provisional stakeholder list (PDF 371 KB)

Published:

04 August 2025
Equality impact assessment (scoping) (PDF 129 KB)

Published:

04 August 2025

Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators

Draft scope post referral (PDF 104 KB)

Published:

13 June 2025
Draft matrix post referral (PDF 110 KB)

Published:

13 June 2025

Notes

Please note that following on from advice received from the company, further information regarding the timelines for this appraisal will be available in due course. In the meantime, NICE will continue to monitor the situation and will provide an update as and when the situation changes.